FindTrial
Sign In

INJECTABLE PLATELATE RICH FIBRIN WITH DFDB AND STANDERD PLATELET RICH FIBRIN TREATED WITH DFDB USED IN THE TREATMENT OF INTRABONY DEFECTS

â??CLINICAL AND RADIOGRAPHIC EVALUATION OF INJECTABLE PLATELET RICH FIBRIN WITH DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT AND STANDARD PLATELET RICH FIBRIN WITH DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT IN THE TREATMENT OF INTRABONY DEFECTS : A RANDOMIZED CONTROLLED CLINICAL TRIALâ??â??

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017664
Enrollment
30
Registered
2019-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: INJECTABLE PRF WITH DFDB IN INTRABONY DEFECTS: THERE IS TOTAL 15 CONTROL SITES WILL BE TREATED WITH S-PRF WITH DFDB Control Intervention1: S-PRF WITH DFDB: THERE IS TOTAL 15 CONTROL SI

Sponsors

SELF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group is 25-60 years. 2. Minimum 20 permanent teeth should be present. 3. Periodontal pocket depth >= 5mm. 4. Evidence of angular defects as determined by IOPA.

Exclusion criteria

Exclusion criteria: 1. Systemically compromised patients and those on medications (corticosteroids/ Bisphosphonate) that may interfere with wound healing. 2. Pregnant women and lactating mother. 3. Active periodontal treatment with in last 6 month. 4. Smokers

Design outcomes

Primary

MeasureTime frame
1. Gingival index 2. Probing pocket depth 3. Clinical attachment level 4. Intrabony defect fill.Timepoint: BASELINE 3 MONTHS 6 MONTHS—

Secondary

MeasureTime frame
1. Gingival index 2. Probing pocket depth 3. Clinical attachment level 4. Intrabony defect fill.Timepoint: BASELINE 3 MONTHS 6 MONTHS—

Countries

India

Contacts

Public ContactHANKU RAMAVATH

KAMINENI INSTITUTE OF DENTAL SCIENCES

periomds@gmail.com8978608194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026